Related references
Note: Only part of the references are listed.Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity
Hal P. Bogerd et al.
VIROLOGY (2011)
XMRV: A New Virus in Prostate Cancer?
Amanda L. Aloia et al.
CANCER RESEARCH (2010)
Xenotropic Murine Leukemia Virus-Related Virus Establishes an Efficient Spreading Infection and Exhibits Enhanced Transcriptional Activity in Prostate Carcinoma Cells
Jason J. Rodriguez et al.
JOURNAL OF VIROLOGY (2010)
Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs
Tobias Paprotka et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome
Otto Erlwein et al.
PLOS ONE (2010)
Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
Ila R. Singh et al.
PLOS ONE (2010)
Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV
Kristin Stieler et al.
PLOS ONE (2010)
No Evidence for XMRV in German CFS and MS Patients with Fatigue Despite the Ability of the Virus to Infect Human Blood Cells In Vitro
Oliver Hohn et al.
PLOS ONE (2010)
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors
Harriet C. T. Groom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States
William M. Switzer et al.
RETROVIROLOGY (2010)
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome
Harriet C. T. Groom et al.
RETROVIROLOGY (2010)
Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors
Robert A. Smith et al.
RETROVIROLOGY (2010)
Mouse DNA contamination in human tissue tested for XMRV
Mark J. Robinson et al.
RETROVIROLOGY (2010)
Disease-associated XMRV sequences are consistent with laboratory contamination
Stephane Hue et al.
RETROVIROLOGY (2010)
Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences
Brendan Oakes et al.
RETROVIROLOGY (2010)
An Endogenous Murine Leukemia Viral Genome Contaminant in a Commercial RT-PCR Kit is Amplified Using Standard Primers for XMRV
Eiji Sato et al.
RETROVIROLOGY (2010)
Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses
Robert A. Smith
RETROVIROLOGY (2010)
XMRV Infection in Patients With Prostate Cancer: Novel Serologic Assay and Correlation With PCR and FISH
Rebecca S. Arnold et al.
UROLOGY (2010)
Xenotropic murine leukemia virus-related virus is susceptible to AZT
Ryuta Sakuma et al.
VIROLOGY (2010)
Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome
Ping Hong et al.
VIROLOGY JOURNAL (2010)
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort
Frank J. M. van Kuppeveld et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections with XMRV (Xenotropic Murine Leukemia Virus-Related Virus), a Human Retrovirus Associated with Prostate Cancer
Seunghee Hong et al.
JOURNAL OF VIROLOGY (2009)
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2009)
Multiple Integrated Copies and High-Level Production of the Human Retrovirus XMRV (Xenotropic Murine Leukemia Virus-Related Virus) from 22Rv1 Prostate Carcinoma Cells
Emily C. Knouf et al.
JOURNAL OF VIROLOGY (2009)
被撤回的出版物: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors (Retracted article. See vol. 111, pg. 12270, 2014)
Robert Schlaberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients
Oliver Hohn et al.
RETROVIROLOGY (2009)
被撤回的出版物: Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome (Retracted article. See vol. 334, pg. 1636, 2011)
Vincent C. Lombardi et al.
SCIENCE (2009)
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein
Nanette Van Damme et al.
CELL HOST & MICROBE (2008)
Human cytidine deaminase APOBEC3H restricts HIV-1 replication
Ying Dang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer
Nicole Fischera et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
The ties that bind a virus to the cell
Robert P. Kruger
CELL (2008)
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil et al.
NATURE (2008)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
Beihua Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant
Anatoly Urisman et al.
PLOS PATHOGENS (2006)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein
M Löchelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
M Stremlau et al.
NATURE (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
DM Sayah et al.
NATURE (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
YH Zheng et al.
JOURNAL OF VIROLOGY (2004)
The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity
K Shindo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication
SR Cheslock et al.
JOURNAL OF VIROLOGY (2000)
Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation
PP Rose et al.
BIOINFORMATICS (2000)
Share Paper
